GeneDx Holdings WGS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $105.99M+23.0% | $86.2M-14.4% | $100.67M-27.2% | $138.3M-65.6% | ||
| $66.29M+18.4% | $55.97M+83.7% | $30.47M— | $0— | ||
| $229.32M+427% | $43.48M+36.3% | $31.91M-81.1% | $168.75M+59.7% | ||
| $49.11M+13.3% | $43.36M+3.3% | $41.99M-69.1% | $135.76M+7.1% | ||
| $268.29M+35.5% | $197.97M+8.6% | $182.34M-14.2% | $212.62M-56.0% | ||
| $45.69M+38.9% | $32.89M+1.3% | $32.48M-37.0% | $51.53M-17.8% | ||
| $13.52M— | $0— | —— | —— | ||
| $168.48M+6.2% | $158.6M-8.1% | $172.63M-7.5% | $186.65M— | ||
| $523.71M+24.9% | $419.38M+0.1% | $418.76M-14.7% | $490.94M-11.4% | ||
| $2.46M-69.1% | $7.95M-22.3% | $10.24M-77.8% | $46.02M+3.0% | ||
| $4.54M+275% | $1.21M+144% | $497K-89.5% | $4.75M— | ||
| $108.91M+98.7% | $54.82M-6.8% | $58.82M-59.2% | $144.3M+42.5% | ||
| $48.18M-7.2% | $51.91M-1.5% | $52.69M+743% | $6.25M-43.2% | ||
| $2.67M-98.5% | $174.13M-8.7% | $190.74M-19.6% | $237.24M+42.9% | ||
| 1B+49,999,900% | 2K0.0% | 2K+100% | 1K-95.8% | ||
| -$1.37B-1.6% | -$1.35B-4.0% | -$1.3B-15.6% | -$1.12B-95.4% | ||
| $308.18M+25.7% | $245.25M+7.6% | $228.02M-10.1% | $253.71M-34.6% | ||
| $523.71M+24.9% | $419.38M+0.1% | $418.76M-14.7% | $490.94M-11.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can GeneDx Holdings cover its short-term obligations?
- Its current ratio is 3.09 — current assets exceed current liabilities.
- Where does GeneDx Holdings's balance sheet data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.